Cerebral venous thrombosis after immune thrombocytopenic purpura and Anti-d immune globulin therapy

Journal of Child Neurology

Volumn 23, Issue 3, 2008, Pages 325-330

  Kayyali, Husam R ^a   Abdelmoity, Ahmed T ^a   Morriss, Craig M ^a   Graf, William D ^b  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Cerebral venous thrombosis; Immune thrombocytopenic purpura; Stroke

Indexed keywords

ACETAZOLAMIDE; METHYLPREDNISOLONE; RHESUS D ANTIBODY; TOPIRAMATE;

ADD ON THERAPY; ARTICLE; BRAIN VEIN; CASE REPORT; CLINICAL FEATURE; CORPUS CALLOSUM; DISEASE COURSE; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOTHERAPY; INTRACRANIAL HYPERTENSION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCHOOL CHILD; SKIN BRUISING; VEIN THROMBOSIS;

ACUTE DISEASE; BRAIN INFARCTION; CHILD; CORPUS CALLOSUM; FEMALE; HUMANS; INTRACRANIAL THROMBOSIS; PHLEBOGRAPHY; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RHO(D) IMMUNE GLOBULIN;

EID: 39049087733     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073807309251     Document Type: Article

References (14)

1. Sebire G., Tabarki B., Saunders DE, et al. Cerebral venous sinus thrombosis in children: Risk factors, presentation, diagnosis and outcome. Brain. 2005; 128: 477-489.
2. van den Bergh WM, van der Schaaf I., van Gijn J. The spectrum of presentations of venous infarction caused by deep cerebral vein thrombosis. Neurology. 2005; 65:192-196.
3. Furuta M., Satoh S., Toriumi T., Nakamura Y. An autopsy case of cerebral sinus thrombosis which showed papilledema and was accompanied by idiopathic thrombocytopenic purpura. Nippon Ganka Gakkai Zasshi. 1991; 95: 199-203.
4. Takashima S., Gotoh F., Fukuuchi Y., et al. Superior sagittal sinus thrombosis as a complication of idiopathic thrombocytopenic purpura. Rinsho Shinkeigaku. 1988; 28: 812-818.
5. Jackson SP, Jane SM, Mitchell CA, et al. Arterial thrombosis associated with immune thrombocytopenia: Presence of a platelet aggregating IgG synergistic with thrombin and adrenalin. Thromb Haemost. 1989; 62: 846-849.
6. Tarantino MD, Young G., Bertolone S., et al. Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children. J Pediatr. 2006; 148: 489-494.
7. Vucic S., Chong PS, Dawson KT, et al. Thromboembolic complications of intravenous immunoglobulin treatment. Eur Neurol. 2004;52: 141-144.
8. Caress JB, Cartwright MS, Donofrio PD, Peacock JEJ. The clinical features of 16 cases of stroke associated with administration of IVIg. Neurology. 2003; 60:1822-1824.
9. Brannagan TH III, Nagle KJ, Lange DJ, Rowland LP Complications of intravenous immune globulin treatment in neurologic disease. Neurology. 1996;47: 674-677.
10. Evangelou N., Littlewood T., Anslow P., Chapel H. Transverse sinus thrombosis and IVIg treatment: A case report and discussion of risk-benefit assessment for immunoglobulin treatment. J Clin Pathol. 2003; 56: 308-309.
11. Dalakas MC High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events. Neurology. 1994;44: 223-226.
12. Wolberg AS, Kon RH, Monroe DM, Hoffman M. Coagulation factor XI is a contaminant in intravenous immunoglobulin preparations. Am J Hematol. 2000; 65: 30-34.
13. Voltz R., Rosen FV, Yousry T., et al. Reversible encephalopathy with cerebral vasospasm in a Guillain-Barre syndrome patient treated with intravenous immunoglobulin. Neurology. 1996; 46: 250-251.
14. Herrmann KA, Sporer B., Yousry TA Thrombosis of the internal cerebral vein associated with transient unilateral thalamic edema: A case report and review of the literature. Am J Neuroradiol. 2004; 25: 1351-1355.